Nicole Lambert
Förmögenhet: 1 M $ per 2026-05-31
Förmögenhet: 1 M $ per 2026-05-31
Nicole Lambert is currently an Independent Director at Arcus Biosciences, Inc. since 2021 and President at Myriad Genetic Laboratories, Inc. Formerly, Ms. Lambert was Chief Operating Officer at Myriad Genetics, Inc. from 2022 to 2023.
Education includes undergraduate studies at Boston College and graduate studies at Icahn School of Medicine at Mount Sinai.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ARCUS BIOSCIENCES, INC. 0,03 % | 2026-06-11 | 43 000 ( 0,03 % ) | 1 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Direktör/Styrelseledamot | 2021-08-03 |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cancer predisposition testing services | President | - |
| Företag | Position | Slut |
|---|---|---|
| MYRIAD GENETICS, INC. | Verksamhetschef | 2023-10-31 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cancer predisposition testing services | Commercial Services |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån